" Idiopathic anaphylaxis successfully treated with omalizumab".

" Idiopathic anaphylaxis successfully treated with omalizumab". Ann Allergy Asthma Immunol. 2019 Sep 27;: Authors: Sanchez-Valenzuela MC, Garcia-Saucedo JC, Motoa G, Carrilo-Martin I, Gonzalez-Estrada A PMID: 31568858 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31568858?dopt=Abstract

Source: Annals of Allergy, Asthma and Immunology - September 26, 2019 Category: Allergy & Immunology Authors: Sanchez-Valenzuela MC, Garcia-Saucedo JC, Motoa G, Carrilo-Martin I, Gonzalez-Estrada A Tags: Ann Allergy Asthma Immunol Source Type: research

More News: Allergy | Allergy & Immunology | Anaphylactic Shock | Asthma | Xolair